Jpn. J. Pharmacol. 81 (1), 12 - 20 (1999)


Analysis of Domain Responsible for Desensitization of 1-Adrenergic Receptor

Chiyuki Akiyama#, Taku Nagao and Hitoshi Kurose*


Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, University of Tokyo,
7 - 3 - 1 Hongo, Bunkyo-ku, Tokyo 113 - 0033, Japan
#Present address: Daiichi Pharmaceutical Co., 1 - 16 - 13, Kitakatushika, Edogawa-ku, Tokyo 134 - 8630, Japan
* To whom correspondence should be addressed.

Abstract: When the wild type 1-adrenergic receptor (WT-1AR) was expressed in Sf9 cells, the 1AR-stimulated adenylyl cyclase activities were desensitized by prior treatment with isoproterenol. The extent of 1AR desensitization was not modified, and the onset was not promoted by the overexpression of G protein-coupled receptor kinase 2 (GRK2), GRK5 or GRK6. However, overexpression of the dominant negative mutant of GRK2 appeared to inhibit desensitization of the 1AR. The change of the potential protein kinase A phosphorylation site located at the intracellular third loop did not affect 1AR desensitization. Desensitization of the truncated mutant, in which nearly all of the serine and threonine residues from the carboxyl terminus were eliminated, was the same as that of the WT-1AR. A deletion mutant that lacked serine and threonine residues of the intracellualr third loop was also desensitized by isoproterenol stimulation. Furthermore, the deletion of serine and threonine residues from both the intracellular third loop and carboxyl terminus did not affect desensitization of the 1AR. These results suggested that phosphorylation by endogenous GRKs in Sf9 cells contributed to desensitization of the 1AR and that the regions other than third intracellular loop and carboxyl terminus may be responsible for 1AR desensitization.

Keywords: 1-Adrenergic receptor, Sf9 cell, G protein-coupled receptor kinase, Protein kinase A,
Desensitization


Copyright The Japanese Pharmacological Society 1999

[Back to TOC]